Havencrest Healthcare Partners, L.P. - Jan 24, 2024 Form 4 Insider Report for Oncology Institute, Inc. (TOI)

Role
10%+ Owner
Signature
/s/ Havencrest Healthcare Partners, L.P., by Matthew Shofner, Vice President, Secretary and Treasurer of the General Partner
Stock symbol
TOI
Transactions as of
Jan 24, 2024
Transactions value $
-$96,835
Form type
4
Date filed
1/26/2024, 07:19 PM
Previous filing
Jan 23, 2024
Next filing
Jan 30, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TOI Common stock Sale -$57.3K -24.9K -47.54% $2.30 27.5K Jan 24, 2024 See footnote F1, F4
transaction TOI Common stock Sale -$24.6K -11.9K -43.21% $2.07 15.6K Jan 25, 2024 See footnote F2, F4
transaction TOI Common stock Sale -$14.9K -6.98K -44.69% $2.14 8.64K Jan 26, 2024 See footnote F3, F4
holding TOI Common stock 8.8M Jan 24, 2024 See footnote F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.15 to $2.44, inclusive. The reporting person undertakes to provide The Oncology Institute, Inc. (the "Issuer"), any security holder of the Issuer, or the staff of the Securities and Exchange Commission ("SEC"), upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (1) to this Form 4.
F2 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.01 to $2.19, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form 4.
F3 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.09 to $2.19, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (3) to this Form 4.
F4 Havencrest Healthcare Partners GP, LLC (the "General Partner") is the record holder of these shares of the Issuer's common stock.
F5 TOI HC I, LLC is the record holder of these 8,801,823 shares of the Issuer's common stock. Havencrest Healthcare Partners, L.P. may be deemed to have beneficial ownership of the shares directly held by TOI HC I, LLC. The General Partner controls Havencrest Healthcare Partners, L.P.

Remarks:

Each reporting person disclaims beneficial ownership of the reported securities except to the extent of such reporting person's pecuniary interest therein.